“One of the few companies in the world with a patented technique for the collection and production of stem cells”
Revatis has developed an innovative process to sample, isolate, differentiate and culture stem cells. These cells are characterized, available in sufficient quantity and express characteristics useful for R&D and clinical developments.
Revatis relies on the scientific publications of a dynamic team and has a solid and evolving patent portfolio.
Revatis has a clear and reasoned approach to the potential of its technology in research and in the clinic and develops partnerships with renowned research centers and downstream companies.
Revatis produces stem cells in a GMP certified aseptic isolator for batch production of cells for R&D and clinical applications.
R&D programs, preclinical and clinical studies bring a new dimension in personalized veterinary and human medicine.